Janssen Biotech has entered into a definitive agreement to acquire a privately-held biopharmaceutical company focused on the red-hot field of cancer immunology. Financial terms of the deal for BeneVir BioPharm are being kept confidential. Janssen Biotech of Horsham, Pennsylvania, is one of the Janssen Pharmaceutical Companies of Johnson & Johnson. BeneVir BioPharm of Rockville specializes in the development of oncolytic immunotherapies. BeneVir uses a proprietary technology to engineer oncolytic…
from https://www.bizjournals.com/baltimore/news/2018/05/03/janssen-biotech-buying-benvir-biopharm-jnj-oncolog.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/173544535887
No comments:
Post a Comment